# clm_61A9104D30AD

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: total_equity  
value: 13,029,600,000 United States dollar  
valid_from: 2022-09-30  
valid_to: 2022-12-31  
published: 2022-10-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_6D580D76E517  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals total equity: 13,029,600,000 United States dollar", as of 2022-09-30 (until 2022-12-31). Claim clm_61A9104D30AD, https://asof.is/claim/clm_61A9104D30AD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532022000038/0000875320-22-000038-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-10-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532022000038/0000875320-22-000038-index.htm (primary, SEC EDGAR 10-Q Q3 FY2022, published 2022-10-28)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | total_equity | 11,933,500,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_61A9104D30AD](/claim/clm_61A9104D30AD.md) | [clm_53E6658C91B5](/claim/clm_53E6658C91B5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.